Gujarat Inject (Kerala) Ltd.
BSE: 524238
₹11.40
₹0.45
(4.11%)
As on 24-Jul-2026IST
Market cap
₹167 Cr
Revenue (TTM)
₹46 Cr
P/E Ratio
55.8
P/B Ratio
12.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
3.4 %
-
ROCE
2.5 %
-
Industry P/E
50.07
-
EV/EBITDA
40.6
-
Debt to Equity
0
-
Book Value
₹0.9
-
EPS
₹1.3
-
Face value
1
-
Shares outstanding
146,490,000
10 Years Aggregate
CFO
₹-6.09 Cr
EBITDA
₹-0.58 Cr
Net Profit
₹2.31 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gujarat Inject
| 218.9 | -6.8 | 21.3 | 381.0 | 145.0 | -- | -- |
|
BSE Healthcare
| 13.7 | 1.8 | 11.7 | 9.7 | 22.8 | 13.4 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Gujarat Inject
| 34.2 | 86.4 | 7.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gujarat Inject
|
11.4 | 167.0 | 46.4 | 3.0 | 8.4 | 27.2 | 55.8 | 12.8 |
| 3,259.5 | 26,666.7 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69 | 16.1 | |
| 323.4 | 1,087.5 | 627.8 | 17.6 | 12.8 | 11.7 | 47.2 | 2.0 | |
| 833.6 | 20,657.6 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.2 | 4.2 | |
| 1,641.2 | 4,067.2 | 370.6 | 97.8 | 27.0 | 12.3 | 41.6 | 4.8 | |
| 802.2 | 1,784.9 | 272.0 | 36.1 | 19.4 | 11.5 | 49.4 | 5.5 | |
| 492.0 | 2,365.9 | 1,431.4 | -1.6 | 6.2 | 0.3 | -- | 1.9 | |
| 1,649.0 | 2,206.4 | 811.3 | 116.2 | 17.2 | 18.5 | 19 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Gujarat Inject
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1991
-
Chairman
--
-
Managing Director
--
-
Headquarters
Vadodara, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Gujarat Inject
What is the current share price of Gujarat Inject (Kerala) Ltd Today?
The share price of Gujarat Inject (Kerala) Ltd is ₹11.40 (BSE) as of 24-Jul-2026 IST. Gujarat Inject (Kerala) Ltd has given a return of 145.02% in the last 3 years.
What is the current PB & PE ratio of Gujarat Inject (Kerala) Ltd?
The P/E ratio of Gujarat Inject (Kerala) Ltd is 55.80 times as on 24-Jul-2026, a 11 premium to its peers’ median range of 50.07 times.
The P/B ratio of Gujarat Inject (Kerala) Ltd is 12.76 times as on 24-Jul-2026, a 228 premium to its peers’ median range of 3.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
135.74
|
1.99
|
|
2023
|
93.33
|
-4.57
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
|
2020
|
0.00
|
0.00
|
What is the 52 Week High and Low of Gujarat Inject (Kerala) Ltd?
The 52-week high and low of Gujarat Inject (Kerala) Ltd are Rs 14.30 and Rs 1.90 as of 25-Jul-2026.
What is the market cap of Gujarat Inject (Kerala) Ltd?
Gujarat Inject (Kerala) Ltd has a market capitalisation of ₹ 167 Cr as on 24-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Gujarat Inject (Kerala) Ltd?
Before investing in Gujarat Inject (Kerala) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.